| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 08/29/2007 | EP1824831A2 Histone deacetylase inhibitors |
| 08/29/2007 | EP1824817A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 08/29/2007 | CN101024627A Nitrogen-containing aromatic derivatives |
| 08/28/2007 | US7262318 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 08/28/2007 | US7262316 by oxidation of aromatic hydroxymethyl, aromatic alkoxymethyl and/or aromatic aldehyde compounds in the presence of acid catalyst and ammonia or ammonium salts |
| 08/28/2007 | US7262302 Antiinflammatory action; rheumatoid arthritis |
| 08/28/2007 | US7262204 Modulation of CCR4 function |
| 08/28/2007 | US7262198 Substituted heterocyclic compounds |
| 08/28/2007 | US7262183 Substituted 5-membered n-heterocyclic compounds and their uses for treating or preventing neurodegenerative diseases |
| 08/28/2007 | CA2389858C New cyclic derivatives of .alpha.-amino-.gamma.-hydroxy-amides, the process for the preparation thereof and the pharmaceutical compounds which contain them |
| 08/28/2007 | CA2210889C Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 08/23/2007 | WO2007073518A9 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 08/23/2007 | WO2007068473A3 Organic compounds |
| 08/23/2007 | WO2007054558A3 Resorcine derivatives and their use as pesticides |
| 08/23/2007 | US20070197803 Process for preparing thiazole by aminomethylation |
| 08/23/2007 | US20070197598 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 08/23/2007 | US20070197472 N-Alkynyl-2-Heteroaryloxyalkylamides For Use As Fungicides |
| 08/23/2007 | US20070196406 1,3-Dimethylbutyl carboxanilides for controlling undesirable micro-organisms |
| 08/23/2007 | US20070194468 Method of preparing organomagnesium compounds |
| 08/23/2007 | CA2641766A1 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 08/23/2007 | CA2641734A1 Acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 08/23/2007 | CA2641673A1 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 08/22/2007 | EP1819691A2 Biaryloxymethylarene carboxylic acids |
| 08/22/2007 | EP1819686A1 5-hydroxy-benzothiazole derivatives having beta-2-adrenorecptor agonist activity |
| 08/22/2007 | EP1819685A1 Substituted oxyguanidines |
| 08/22/2007 | EP1819330A1 5-carboxamido substitued thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family |
| 08/22/2007 | EP1742903B1 Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof |
| 08/22/2007 | CN1332954C Dipeptidyl peptidase IV effectors |
| 08/22/2007 | CN1332942C Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists |
| 08/22/2007 | CN1332921C Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 08/22/2007 | CN101020677A Cyanoacrylate compounds and their application in pesticide |
| 08/22/2007 | CN101020668A Process of synthesizing 4-methyl-5-formyl thiazole |
| 08/21/2007 | US7259262 Arylazole derivatives, their manufacture and use as pharmaceutical agents |
| 08/21/2007 | US7259178 Containing an oxazole ring, e.g., 1,1,1,3,3,3-Hexafluoro-2-{4-[[5-methyl-2-(3-trifluoromethyl-phenyl)-oxazol-4-ylmethyl]-(2,2,2-trifluoro-ethyl)-amino]-phenyl}-propan-2-ol; the compounds bind to and selectively activate LXR alpha and LXR beta; used to treat diseases such as atherosclerosis and diabetes |
| 08/21/2007 | US7259176 Process for the preparation of the insulin sensitizer |
| 08/21/2007 | US7259175 Alkanoic acids substituted with a group containing pyridinyl-, pyrimidinyl- or pyrazinyl-phenyl linked through a thiazolyl- or oxazolyl- phenyl group; e.g., 3-[4-(2-{2-[6-(2-Fluoro-phenyl)-pyridin-3-yl]-5-methyl-thiazol-4-yl}-ethoxy)-2-methyl-phenyl]-propionic acid; treating diabetes and atherosclerosis |
| 08/21/2007 | US7259166 Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators |
| 08/21/2007 | US7259162 Benzazole derivatives and their use as JNK modulators |
| 08/21/2007 | CA2237348C Process for preparing 2-chlorothiazole compounds |
| 08/16/2007 | WO2007092558A2 Sulfonamide derivatives to treat infection with hepatitis c virus |
| 08/16/2007 | WO2007092190A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
| 08/16/2007 | WO2007091406A1 Novel compound and optical recording material employing the compound |
| 08/16/2007 | WO2007091396A1 Novel amidopropionic acid derivative and pharmaceutical product containing same |
| 08/16/2007 | WO2007091313A1 Cytokine production inhibitor and heterocyclic phenoxy derivative |
| 08/16/2007 | WO2007090434A1 Substituted aryl oximes |
| 08/16/2007 | WO2007046513A3 Benzoylurea compounds and use thereof |
| 08/16/2007 | WO2007041365B1 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
| 08/16/2007 | US20070191447 Novel heterocyclic compound |
| 08/16/2007 | US20070191441 Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1b (ptb1b) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes |
| 08/16/2007 | US20070191439 reacting propionic anhydride with N-(6-Amino-4,5,6,7-tetrahydro-benzothiazol-2-yl)-acetamide and subsequent reduction by treatment with NaBH4 and I2 to obtain amino derivative, deprotection of primary amino group to form pramipexole or salt formation of pramipexole |
| 08/16/2007 | US20070191390 Substituted heterocyclic compounds |
| 08/16/2007 | CA2641307A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 08/16/2007 | CA2640229A1 Sulfonamide derivatives to treat infection with hepatitis c virus |
| 08/15/2007 | EP1818334A1 Anti-trypanosomiasis agent |
| 08/15/2007 | EP1818333A1 Vanilloid receptor ligands and their use in treatments |
| 08/15/2007 | EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1818322A1 Pyrene compound and, utilizing the same, light emitting transistor device and electroluminescence device |
| 08/15/2007 | EP1817309A1 Acetamide compounds as fungicides |
| 08/15/2007 | EP1656360B1 Thiazoline derivatives as selective androgen receptor modulators (sarms) |
| 08/15/2007 | EP1480640B1 Peroxisome proliferator activated receptor modulators |
| 08/15/2007 | EP1385825B1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 08/15/2007 | EP1354879B1 Dihydronaphthalene derivative compounds and drugs containing these compounds as the active ingredient |
| 08/15/2007 | EP1353669B1 Method for treating glaucoma |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN101018773A Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes. |
| 08/15/2007 | CN101018761A Methods and compositions for modulating sphingosine-1-phosphate(S1P) receptor activity |
| 08/15/2007 | CN101016279A Method of synthesizing 2-fluorobromomethylbenzothiazole |
| 08/15/2007 | CN101016278A 2-difluorophenoxymethylbenzimidazole and synthesis method thereof |
| 08/15/2007 | CN101016277A Second anabasine insecticide JT-L001 and chemical synthesis method thereof |
| 08/14/2007 | US7256205 2-Aminothiazole histamine H2 receptor antagonists such as famotidine or nizatidine to which is linked at least one NO and/or NO2 group; treating inflammations including gastrointestinal disorders and reducing the gastrointestinal toxicity associated with the use of NSAIDS |
| 08/14/2007 | US7256204 6-(4-biphenylyl)methoxy-2-(2-(N,N-dimethylamino)ethyl)tetralin for example; inhibiting amyloid-beta protein production; for neurodegenerative diseases such as Alzheimer's disease |
| 08/09/2007 | WO2007089101A1 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same |
| 08/09/2007 | WO2007089044A1 Process for production of aromatic compound |
| 08/09/2007 | WO2007087906A1 Fungicide n-cycloalkyl-benzyl-amide derivatives |
| 08/09/2007 | WO2007014290B1 Fungicidal carboxamides |
| 08/09/2007 | US20070185174 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 08/09/2007 | US20070185110 pollinosis, bronchial asthma, atopic dermatitis, urticaria; endometriosis and hysteromyoma |
| 08/09/2007 | US20070185109 Idene derivatives and process for the preparation thereof |
| 08/09/2007 | US20070185105 Calcium channel blockers |
| 08/09/2007 | US20070185059 Antiallergic agents |
| 08/09/2007 | CA2640454A1 Compounds and methods for modulating protein trafficking |
| 08/09/2007 | CA2637336A1 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same |
| 08/09/2007 | CA2632870A1 Fungicide n-cycloalkyl-benzyl-amide derivatives |
| 08/08/2007 | EP1816128A1 Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof |
| 08/08/2007 | EP1816127A1 Triazine derivatives for use as selective npy (y5) antagonists |
| 08/08/2007 | EP1814593A1 An oral preparation having improved bioavailability |
| 08/08/2007 | EP1709019B1 Thiazole derivatives and use thereof |
| 08/08/2007 | EP1532111B1 2,5-disubstituted 3-mercaptopentanoic acid |
| 08/08/2007 | CN1330641C Activator for peroxisome proliferator-responsive receptor delta |
| 08/08/2007 | CN101014589A Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 08/08/2007 | CN101014565A Diarylsulfones as 5-HT2a antagonists |
| 08/08/2007 | CN101012207A Fluorescent probe for detecting ultra-oxygen anion free radical, synthesis method and use |
| 08/07/2007 | US7253287 Fluorophore of a substituted fluorene ring functionalized with amine-reactive fluorescent probes covalently attaching to proteins and antibodies; high fluorescence quantum yields, high photostability |
| 08/07/2007 | US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 08/07/2007 | US7253283 9-[4-[4-[[2-(2,2,2-trifluoroethoxy)benzoyl]amino]-1-piperidinyl]butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide; non-steroidal modulator of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity, obesity, diabetes, inflammatory and immune diseases |
| 08/07/2007 | US7253197 2-aryl- or heteroarylamino- 5-cycloalkanoyl-, aroyl-, or heteroaroyl- thiazoles; treatment or prophylaxis of obesity, especially in combination with orlistat. |
| 08/07/2007 | US7253196 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| 08/07/2007 | US7253188 Aminobenzamide derivative |
| 08/07/2007 | US7253173 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate |